IgG autoantibodies have been reported to induce immune responses against self-tissues through FcγRs, including CD16a and CD32a, on the surface of effector cells in some autoimmune diseases, such as ITP and systemic lupus erythematosus [3, 25, 26]. This evidence concerns the gene FCGR2A and autoimmune thrombocytopenic purpura.